Holy Grail: the journey towards disease modification in asthma

William W. Busse, Erik Melén, Andrew N. Menzies-Gow

Source: Eur Respir Rev, 31 (163) 210183; 10.1183/16000617.0183-2021
Journal Issue: March

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
William W. Busse, Erik Melén, Andrew N. Menzies-Gow. Holy Grail: the journey towards disease modification in asthma. Eur Respir Rev, 31 (163) 210183; 10.1183/16000617.0183-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The search for the Holy Grail and the upper airway resistance syndrome. New data are welcome
Source: Eur Respir J 2001; 17: 835-837
Year: 2001


Evaluation of sleepiness: new available tools or still searching for the Holy Grail?
Source: Virtual Congress 2021 – Digital health meets sleep breathing disorders
Year: 2021


Treatable traits: a step closer to the “holy grail” of asthma control?
Source: Eur Respir J, 55 (3) 2000002; 10.1183/13993003.00002-2020
Year: 2020



COPD: Still a Cinderella?
Source: Eur Respir J 2003; 22: Suppl. 45, 67s
Year: 2003

Asthma attacks in children are always preceded by poor asthma control: myth or maxim?
Source: Breathe, 16 (3) 186; 10.1183/20734735.0169-2020
Year: 2020



Pharmacogenetics and asthma: false hope or new dawn?
Source: Eur Respir J 2007; 29: 1239-1245
Year: 2007



Infection: friend or foe to the development of asthma?
Source: Eur Respir J 2001; 18: 744-747
Year: 2001


Cardiovascular disease and COPD: dangerous liaisons?
Source: Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018
Year: 2018



The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017



Interleukin-6 as a biomarker for asthma: hype or is there something else?
Source: Eur Respir J 2016; 48: 979-981
Year: 2016


What’s new in the epidemiology of asthma?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021


Complete remission of asthma: Myth or reality?
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010

What’s new in paediatric asthma?
Source: International Congress 2018 – Paediatric Year in Review
Year: 2018


A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma
Source: Eur Respir J 2003; 22: 397-398
Year: 2003


The quest for the grail: multidimensional efforts for understanding and targeting severe asthma
Source: Eur Respir J 2015; 46: 1227-1231
Year: 2015


Paediatric asthma: where to go?
Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine
Year: 2013


Paediatric asthma: where to go?
Source: Eur Respir Rev 2012 21:173-174
Year: 2012